Australia
Brazil
Canada
Germany
India
Ireland
Japan
Mexico
New Zealand
Philippines
South Africa
United Kingdom
Hidden Brain
Also in Science
Science
IMPACT Medicom
by IMPACT Medicom
Today: #197 in Science, Canada on our combined chart.
Share this ranking
Claiming needs an RSS feed. Contact us.
Chart positions today · United States
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the India charts we track today.
Not on the Japan charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like IMPACT Medicom, try…
Radiolab
Also in Science
Ologies with Alie Ward
Also in Science
StarTalk with Neil deGrasse Tyson
Also in Science
Science Vs
Also in Science
Boring History for Sleep
Also in Science
Ranking history · United States
No ranking history for this show in United States over the last 14 days.
Latest episodes
-
Canadian Hematology Consensus Group: RR FL Consensus Paper Discussion
August 19, 2026 · 13 minThe Canadian Hematology Consensus Group, or CHCG, is a national collaboration of Canadian hematologists and healthcare professionals dedicated to improving patient care through the development of National consensus recommendations in…
-
Introduction to the Canadian Hematology Consensus Group (CHCG)
May 29, 2026 · 20 minDr. Carolyn Owen, Chair of the Canadian Hematology Consensus Group (CHCG), introduces the CHCG and discusses its mission to develop evidence-based Canadian consensus recommendations in areas of unmet need in hematology. In this video, Dr…
-
Double-Exposed CLL/SLL: A Canadian Perspective
December 2, 2025 · 23 minIn this episode with Dr Robert Puckrin, we discuss the unmet needs of double-exposed patients with CLL/SLL, as well as the current and novel treatments that can address this gap. Our guest Dr. Puckrin is a Hematologist and Clinician…
-
Thoracic Surgery Series: Resection after Neoadjuvant Immunotherapy
November 10, 2025 · 10 minIn this podcast episode, Dr. Dimitrios Coutsinos describes a video capsule series involving three educational videos of lung resections using minimally invasive video-assisted thoracic surgery (VATS) following neoadjuvant immunotherapy in…
-
Highlights from EHA/ICML 2025: International Perspective on CLL
June 26, 2025 · 41 minIn this podcast episode, we discuss clinical trial updates in chronic lymphocytic leukemia from the 2025 European Hematology Association annual congress in Milan, Italy and the 18th International Conference on Malignant Lymphoma in Lugano…
Show 7 more episodesShow fewer episodes
-
Prise en charge de la PN associée au BV utilisé pour le traitement de première intention du cH
March 27, 2025 · 15 min(FRENCH) In this podcast episode, which follows this introduction in French, Dr Christopher Lemieux summarizes a paper by Dr Abramson, et al. on the management of Peripheral Neuropathy Associated with Brentuximab Vedotin in the Frontline…
-
Management of Peripheral Neuropathy Associated with Brentuximab Vedotin in cHL
March 26, 2025 · 20 minIn this podcast episode, Dr. Michael Chu discusses the management of peripheral neuropathy associated with the use of brentuximab vedotin for the first-line treatment of classical Hodgkin Lymphoma. Our Guest Dr. Michael Chu is a…
-
ASH 2024: Updates on CLL
December 29, 2024 · 27 minIn this podcast episode, Dr. Versha Banerji, a Canadian hematologist from Manitoba and Dr. Jennifer Brown, an internationally renowned hematologist from the United States, discuss data on the treatment of CLL presented at the American…
-
Integrating Non-Covalent BTK Inhibitors in CLL: Navigating a Rapidly Evolving Treatment Landscape
September 4, 2024 · 18 minIn this podcast episode, Dr. Versha Banerji discusses the role of non-covalent BTK inhibitors for the treatment of CLL. Our Guest: Dr. Versha Banerji is a Clinician Scientist at CancerCare Manitoba and Senior Scientist at the Research…
-
Highlights from EHA 2024 - Updates on the Treatment of CLL
July 2, 2024 · 42 minIn this podcast episode, three of Canada’s top hematologists discuss data on the treatment of CLL presented at the European Hematology Association (or EHA) meeting in Madrid, Spain. The discussion involves an analysis of the data from 6…
-
LIVE FROM EHA 2024 - Sonrotoclax plus Zanubrutinib in R/R CLL
June 21, 2024 · 17 minIn this episode of our podcast, recorded at the European Hematology Association (EHA) meeting in Madrid, Spain, we discuss updated results of the BGB-11417-101 trial with Dr. Stephen Opat. The BGB-11417-101 trial examined the efficacy and…
-
Cutting Edge Advances in the Treatment of Lung Cancer
April 19, 2024 · 15 minIn this episode, Dr. Barbara Melosky discusses cutting edge approaches to the treatment of Lung Cancer, including the use of artificial intelligence and novel therapeutic approaches such as cancer vaccines and new targeted therapies. Our…
About the show
We are a medical communications company with a passion for developing high-quality content. We write & design content for healthcare professionals and patients in a variety of therapeutic areas. If you like our podcast, please take the time to rate it and subscribe. See our website for more information, video capsules, and podcasts at: https://www.impactmedicom.com.